Compounds > nad
Page last updated: 2024-08-17

nad and B16 Melanoma

nad has been researched along with B16 Melanoma in 8 studies

Research

Studies (8)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (25.00)18.2507
2000's2 (25.00)29.6817
2010's4 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Fu, J; Li, Q; Liu, Y; Min, W; Song, N; Wang, H; Yu, Y; Yuan, K; Zhang, X; Zhang, Y; Zheng, X; Zhou, N1
Alriquet, M; Calloni, G; Lang, WH; Martínez-Limón, A; Vabulas, RM; Wittig, I1
Bonder, CS; Pastore, MN; Roberts, MS; Studier, H1
Bailey, N; Graber, D; Kudugunti, SK; Moridani, MY; Srivenugopal, K; Vad, NM1
Kudugunti, SK; Moridani, MY; Naik, BU; Srivenugopal, KS; Vad, NM; Whiteside, AJ; Yusuf, MA1
Moridani, MY1
Bubis, M; Zisapel, N1
Furcht, LT; Lester, BR; McCarthy, JB; Smith, RS; Sun, ZQ; Weinstein, LS1

Other Studies

8 other study(ies) available for nad and B16 Melanoma

ArticleYear
Gene silencing of indoleamine 2,3-dioxygenase 2 in melanoma cells induces apoptosis through the suppression of NAD+ and inhibits in vivo tumor growth.
    Oncotarget, 2016, May-31, Volume: 7, Issue:22

    Topics: Animals; Apoptosis; Cell Line, Tumor; Cell Movement; Cell Proliferation; G1 Phase Cell Cycle Checkpoints; Gene Expression Regulation, Enzymologic; Gene Expression Regulation, Neoplastic; Indoleamine-Pyrrole 2,3,-Dioxygenase; Male; Melanoma, Experimental; Mice; Mice, Inbred C57BL; NAD; Neoplasm Invasiveness; Reactive Oxygen Species; RNA Interference; RNA, Small Interfering; RNAi Therapeutics; Signal Transduction; Skin Neoplasms; Time Factors; Transfection; Tumor Burden

2016
Recognition of enzymes lacking bound cofactor by protein quality control.
    Proceedings of the National Academy of Sciences of the United States of America, 2016, 10-25, Volume: 113, Issue:43

    Topics: Animals; Coenzymes; Flavoproteins; Gene Expression Profiling; Gene Expression Regulation; HSP70 Heat-Shock Proteins; Melanoma, Experimental; Mice; Models, Molecular; NAD; NAD(P)H Dehydrogenase (Quinone); Protein Aggregates; Protein Structure, Secondary; Proteolysis; Proteome; Proteomics; Pyridoxal Phosphate; Riboflavin; Thiamine Pyrophosphate; Tumor Cells, Cultured; Ubiquitin-Protein Ligases

2016
Non-invasive metabolic imaging of melanoma progression.
    Experimental dermatology, 2017, Volume: 26, Issue:7

    Topics: Animals; Cell Line, Tumor; Disease Progression; Epidermis; Female; Keratinocytes; Melanoma; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Microscopy, Fluorescence, Multiphoton; NAD; Neoplasm Staging; Skin Neoplasms

2017
Efficacy of acetaminophen in skin B16-F0 melanoma tumor-bearing C57BL/6 mice.
    International journal of oncology, 2009, Volume: 35, Issue:1

    Topics: Acetaminophen; Animals; Antineoplastic Agents; Ascorbic Acid; Cell Line, Tumor; Cell Survival; Dose-Response Relationship, Drug; Glutathione; Humans; Inhibitory Concentration 50; Kidney; Lipid Peroxidation; Liver; Male; Melanoma, Experimental; Mice; Mice, Inbred C57BL; Monophenol Monooxygenase; NAD; Oxidation-Reduction; Phenacetin; Reactive Oxygen Species; RNA Interference; Skin Neoplasms; Sulfhydryl Compounds; Time Factors

2009
Biochemical mechanism of caffeic acid phenylethyl ester (CAPE) selective toxicity towards melanoma cell lines.
    Chemico-biological interactions, 2010, Oct-06, Volume: 188, Issue:1

    Topics: Animals; Apoptosis; Ascorbic Acid; Caffeic Acids; Cell Line, Tumor; Glutathione; Male; Melanoma, Experimental; Monophenol Monooxygenase; NAD; Phenylethyl Alcohol; Rats; Rats, Sprague-Dawley; Spectrophotometry, Ultraviolet

2010
Biochemical basis of 4-hydroxyanisole induced cell toxicity towards B16-F0 melanoma cells.
    Cancer letters, 2006, Nov-18, Volume: 243, Issue:2

    Topics: Animals; Anisoles; Antineoplastic Agents; Ascorbic Acid; Cell Line, Tumor; Cell Proliferation; Cell Survival; Cyclic N-Oxides; Dicumarol; Dithiothreitol; Dose-Response Relationship, Drug; Glutathione; Heptanes; Horseradish Peroxidase; Hydrogen Peroxide; Melanoma, Experimental; Mice; Models, Biological; Monophenol Monooxygenase; NAD; Oxygen; Pyrogallol; Spectrophotometry, Ultraviolet; Spin Labels; Time Factors

2006
Involvement of cGMP in cellular melatonin responses.
    Biology of the cell, 1999, Volume: 91, Issue:1

    Topics: 3',5'-Cyclic-GMP Phosphodiesterases; Animals; Cholera Toxin; Cyclic GMP; Dibutyryl Cyclic GMP; GTP-Binding Proteins; Guanylate Cyclase; Melanoma, Experimental; Melatonin; Mice; NAD; Neoplasm Proteins; Signal Transduction; Tumor Cells, Cultured

1999
The role of G-protein in matrix-mediated motility of highly and poorly invasive melanoma cells.
    International journal of cancer, 1991, Apr-22, Volume: 48, Issue:1

    Topics: Adenylate Cyclase Toxin; Animals; Cell Line; Cell Movement; Cholera Toxin; Clone Cells; Cyclic AMP; Extracellular Matrix; GTP-Binding Proteins; Melanoma, Experimental; Mice; NAD; Neoplasm Invasiveness; Nucleic Acid Hybridization; Pertussis Toxin; RNA, Neoplasm; Tumor Stem Cell Assay; Virulence Factors, Bordetella

1991